Biological Industries USA Adds Human Mesenchymal Cells to its Stem Cell Portfolio in Partnership with StemExpress
Biological Industries USA (BI-USA), a division of Biological Industries Beit Haemek Israel (BI), and StemExpress announce a strategic partnership for the non-exclusive worldwide distribution of StemExpress’ human bone marrow-derived mesenchymal stem cells (BM-MSCs).
“Partnering with StemExpress enables BI-USA to bring full cell culture solutions to our customers,” commented Daniel Haus, PhD, Scientific Affairs Manager at BI-USA. “We can now provide high quality mesenchymal cells right alongside our clinical quality NutriStem® MSC Medium.”
Human BM-MSCs are widely used in the fields of regenerative medicine and cell therapy. StemExpress uses proprietary technology to isolate high-quality, readily expandable BM-MSCs from healthy donors. StemExpress, BI-USA, and their partner labs have performed extensive evaluations of the performance of StemExpress Human BM-MSCs in combination with NutriStem® MSC Medium, resulting in dramatically improved MSC expansion when compared to industry standard MSC culture conditions.
“We are excited about our new partnership with Biological Industries USA,” said Matthew Phillips, Director, Business Development at StemExpress. “Working together, we can continue to accelerate the progress of global medical research and support those looking to provide solutions to the challenges many researchers face.”
About Biological Industries USA (BI-USA)
Biological Industries USA (www.bioindusa.com) is the US commercialization arm of BI, with facilities in Cromwell, Connecticut. Members of the BI-USA team share expertise and a history of innovation and success in the development of leading-edge technologies in stem cell research, cellular reprogramming, and regenerative medicine.
About Biological Industries (BI)
Biological Industries (www.bioind.com) is one of the world’s leading and trusted suppliers to the life sciences industry, with over 35 years’ experience in cell culture media development and GMP manufacturing. BI’s products range from classical cell culture media, to supplements and reagents for stem cell research and cell therapy applications, to serum and serum-free media products. BI is committed to a Culture of Excellence through advanced manufacturing and quality-control systems, regulatory expertise, in-depth market knowledge, and extensive technical customer-support, training, and R&D capabilities.
StemExpress (www.stemexpress.com) is a leading provider of human derived blood products and laboratory services used to support global research to accelerate the prevention and cure of significant medical conditions. Samples are collected and processed in one of the multiple StemExpress collection centers located throughout the United States. StemExpress has established a reliable, effective and streamlined process guaranteeing every sample has the highest purity, viability, and quality.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181030005642/en/